CAS Number1000998-59-3
SynonymsN-(3-{[2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methoxy}benzyl)-N-(methoxycarbonyl)glycine; 7ha; BMS-687453
Molecular FormulaC22H21ClN2O6
Molecular Weight444.865
Density1.3±0.1 g/cm3
Boiling Point642.7±65.0 °C at 760 mmHg
AppearanceWhite to off-white solid
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1000998-59-3 |
| Catalog No. | 2A-1170330 |
| Chinese Name | BMS-687453 |
| Synonyms | N-(3-{[2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methoxy}benzyl)-N-(methoxycarbonyl)glycine; 7ha; BMS-687453 |
| Molecular Formula | C22H21ClN2O6 |
| Molecular Weight | 444.865 |
| Density | 1.3±0.1 g/cm3 |
| Boiling Point | 642.7±65.0 °C at 760 mmHg |
| Appearance | White to off-white solid |
| Storage Condition | -20℃ |
| Application | BMS-687453 is a potent and selective PPARα agonist with EC50 and IC50 of human PPARα of 10 nM and 260 nM respectively; it weakly inhibits the activity of PPARγ with EC50 and IC50 values of 4100 nM a |
| PubChem ID | 26679168 |
| SMILES | COC(=O)N(CC(=O)O)Cc1cccc(OCc2nc(-c3ccc(Cl)cc3)oc2C)c1 |
| InChI | InChI=1S/C22H21ClN2O6/c1-14-19(24-21(31-14)16-6-8-17(23)9-7-16)13-30-18-5-3-4-15(10-18)11-25(12-20(26)27)22(28)29-2/h3-10H,11-13H2,1-2H3,(H,26,27) |
| InChI Key | UJIBXDMNCMEJAY-UHFFFAOYSA-N |
| Transport Info | Product name: BMS-687453 |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| BS-181 hydrochloride | 1092443-52-1 | 2A-1170325 |
| PLX647 | 873786-09-5 | 2A-1170326 |
| STK321130 | 923562-23-6 | 2A-1170327 |
| (3-Chlorophenyl)[3,4-dihydro-6,7-dimethoxy-1-[(4-methoxyphenoxy)methyl]-2(1H)-isoquinolinyl]methanone | 486427-17-2 | 2A-1170328 |
| PLX3397 (Pexidartinib) | 1029044-16-3 | 2A-1170329 |
| GP 2A | 919077-81-9 | 2A-1170332 |
| AI-10-49 | 1256094-72-0 | 2A-1170333 |
| 4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione | 865854-05-3 | 2A-1170336 |
| GW 627368X | 439288-66-1 | 2A-1170337 |
| LY 2874455 | 1254473-64-7 | 2A-1170341 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS